Pulling SEC filings + quote and writing the call…
IMMX
Immix Biopharma, Inc.
Next earnings Aug 6, 2026 · consensus $-0.19 EPS
$8.72
▼ -4.49%$8.72▲ +263.33%
over 1Y
L $1.96EODHDH $11.12
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-4.5%
1W+7.7%
1M-1.6%
3M-9.9%
YTD+60.6%
1Y+263.3%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Buy
Conservative balance sheet (liabilities/equity 0.12x).
Immix Biopharma, Inc. shows limited reported revenue, and -31.4% ROE.
Sources: SEC EDGAR (CIK 0001873835, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 12:29:44 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.